HIV-ANTIGENE UND -ANTIKÖRPER

Patent europeic · EP2961427 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2961427
Numer da la dumonda
EP14756908
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-02-2014
Publitgà
06-01-2016
Concedì
25-03-2020
La protecziun finescha il pli tard
27-02-2034
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61K 39/395 (2006.01)
Prioritad
US 201361770974 P 28.02.2013
Dumonda PCT
PCT/US2014/019612 28.02.2014
Publicaziun PCT
WO2014/134547 04.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  3. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  4. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  5. 16-04-2020

    Represchentant inscrit

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 16.04.2020

  6. 25-03-2020

    Concedì

    Published in Swissreg on 25.03.2020

Partidas

Possessur

GNVIE, LLC

2135 14th Avenue, San Francisco, CA 94116, US

Represchentant

TR-IP Consulting Sàrl

TR-IP Consulting LLC

Route du Coutset 18, 1485 Nuvilly

En liquidaziun

Inventur

KILLIAN, M., Scott

San Francisco, CA 94116, US

VYAS, Girish

San Francisco, CA 94116, US

SZAKAL, Evelin

San Francisco, CA 94116, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.